Nitrosamines are known environmental contaminants that have recently been identified in drug products. They are a substance of concern because they have even been identified as part of a group of high potency mutagenic carcinogens referred to as a “cohort of concern” (as per ICH’s M7 Mutagenic Impurities guidelines). Download this infographic for a primer on the testing, regulations, and reporting of nitrosamines in pharmaceuticals.